Korea confirmed its first case of the new Omicron variant XL on Tuesday, although authorities were quick to say they weren't concerned.
SK Bioscience’s Covid-19 vaccine candidate GBP510 won approval to start Phase 3 clinical trials, the company said Tuesday.
Korea JoongAng Daily Sitemap
